IV COHORT STUDIES [27] Were the two groups similar and recruited from the same population? Were the exposures measured similarly to assign people to both exposed and unexposed groups? Was the exposure measured in a valid and reliable way? Were confounding factors identified? Were strategies to deal with confounding factors stated? Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? Were the outcomes measured in a valid and reliable way? Was the follow-up time reported and sufficient to be long enough for outcomes to occur? Was follow-up complete, and if not, were the reasons for loss of follow-up described and explored? Were strategies to address incomplete follow-up utilised? Was appropriate statistical analysis used?
Author	Q1	Q2	Q3	Q4	Q5	Q6	Q7	Q8	Q9	Q10	Q11
Akhtar et al. (2021) [38]	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y
Akuamoa-Boateng et al. (2020) [33]	UC	Y	NA	N	N	Y	Y	Y	Y	NA	Y
Araujo et al. (2020) [56]	UC	Y	NA	N	N	Y	Y	Y	Y	NA	Y
Brenes Sanchez et al. (2021) [39]	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y
Caravatta et al. (2020) [35]	UC	Y	NA	N	N	Y	UC	Y	Y	UC	Y
Clark et al. (2021) [48]	UC	Y	NA	N	N	Y	Y	Y	Y	NA	Y
Earp et al. (2020) [40]	UC	Y	NA	N	N	Y	Y	Y	Y	NA	Y
Maganty et al. (2020) [30]	Y	Y	Y	Y	Y	Y	Y	Y	Y	NA	Y
Narayanan et al. (2021) [44]	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y
Patt et al. (2020a) [65]	UC	Y	NA	N	N	Y	Y	Y	Y	NA	Y
Romani et al. (2021) [32]	UC	Y	NA	N	N	Y	Y	Y	Y	Y	Y
Shannon et al. (2020) [45]	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y
Wai et al. (2021) [41]	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y	Y